Silicified Cell Replicas Preserve Structure for Immune Activation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing vaccines often rely on harmless versions of microbes, which may not effectively stimulate cell-mediated immune responses against cancer, and there is a need for stable and immunogenic vaccine candidates that can overcome tolerance mechanisms.
Innovation Solution
The development of silicified cell replicas, including silicified bacterial and tumor cells, which are structurally intact and resistant to environmental conditions, and can be modified with pathogen-associated molecular patterns (PAMPs) to enhance immune response activation and antigen presentation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If harmless versions of microbes are used in vaccines, then safety is improved, but immune response activation deteriorates
Solution Approach 1:
The patent creates silicified replicas that are copies of pathogenic cells (bacterial, fungal, or tumor cells) which preserve the immunogenic surface features and internal structures of the original pathogenic cells while being non-viable and non-replicating. These replicas serve as safe substitutes that maintain the ability to stimulate immune responses without the risks associated with live pathogens
Solution Approach 2:
The patent transforms the physical and chemical parameters of cellular material through silicification, converting organic cellular structures into siliceous replicas with different material properties. This parameter change preserves the surface morphology and antigenic features while eliminating biological activity, creating a safe but immunogenic vaccine candidate
2Stability of the object's composition
If silicified cell replicas are used, then stability and environmental resistance are improved, but manufacturing complexity worsens
Solution Approach 1:
The patent performs preliminary fixation of cellular material before silicification to preserve structural integrity. The fixation step pre-stabilizes the cellular architecture, ensuring that the subsequent silicification process captures the correct morphological features without degradation, thereby simplifying the overall manufacturing process
3Adaptability or versatility
If tumor cells are used for vaccination, then personalized cancer treatment is improved, but immune tolerance mechanisms worsen
Solution Approach 1:
The patent creates composite structures by combining silicified tumor cell replicas with adjuvants or other immunomodulatory components. This composite approach enhances the immunogenicity of the tumor antigens presented by the replicas, helping to overcome immune tolerance mechanisms that typically prevent effective anti-tumor immune responses
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Silicified cell replicas effectively stimulate antigen-presenting cells to process and present tumor antigens, overcoming tolerance mechanisms and inducing strong immune responses, making them potential candidates for personalized cancer vaccines.
Implementation Method 1
the fixed cells are subjected to a silicification process in which silica deposits on the surface and within the structure of the fixed cells
Implementation Method 2
Silicified cell replicas effectively stimulate antigen-presenting cells to process and present tumor antigens, overcoming tolerance mechanisms and inducing strong immune responses
Data Source
AI summary
A silicified cell replica includes a silicified cell or a silicified subcellular fragment. The silicified cell replica may be used to induce an immunological response, treat a bacterial infection, or treat a patient with cancer.